Akzo Nobel Valuation

Q: What is the Fair Price of AKZO.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

AKZO.F ($65.6) is trading below our estimate of [[fair value]] ($150.36)

Is AKZO.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AKZO.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AKZO.F ($65.6) is trading below our estimate of fair value ($150.36)

Significantly Below Fair Value: AKZO.F is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AKZO.F?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for AKZO.F. This is calculated by dividing AKZO.F's market cap by their current preferred multiple.
What is AKZO.F's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	€10.02b

AKZO.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	11x
PEG Ratio	1.5x

Price to Earnings Ratio vs Peers

How does AKZO.F's PE Ratio compare to its peers?

The above table shows the PE ratio for AKZO.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	18.1x
EMN Eastman Chemical	13.1x	9.9%	US$11.7b
AXTA Axalta Coating Systems	25.4x	18.3%	US$8.3b
CE Celanese	7x	-1.5%	US$13.6b
RPM RPM International	26.8x	10.9%	US$16.3b
AKZO.F Akzo Nobel	17.9x	12.0%	US$10.0b

Price-To-Earnings vs Peers: AKZO.F is good value based on its Price-To-Earnings Ratio (17.9x) compared to the peer average (18.1x).

Price to Earnings Ratio vs Industry

How does AKZO.F's PE Ratio compare vs other companies in the US Chemicals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	17.3%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	17.3%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: AKZO.F is good value based on its Price-To-Earnings Ratio (17.9x) compared to the US Chemicals industry average (24.4x).

Price to Earnings Ratio vs Fair Ratio

What is AKZO.F's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AKZO.F PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	17.9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate AKZO.F's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AKZO.F forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	US$65.60	US$79.62 +21.4%	10.5%	US$98.61	US$62.85	n/a	19
Oct ’25	US$68.05	US$81.87 +20.3%	12.6%	US$101.33	US$60.13	n/a	19
Sep ’25	n/a	US$79.58 0%	13.6%	US$99.36	US$57.87	n/a	18
Aug ’25	US$60.10	US$79.07 +31.6%	13.3%	US$98.50	US$57.37	n/a	18
Jul ’25	n/a	US$81.55 0%	13.4%	US$100.93	US$56.91	n/a	18
Jun ’25	n/a	US$84.44 0%	9.7%	US$101.40	US$70.12	n/a	18
May ’25	n/a	US$84.09 0%	9.8%	US$100.84	US$69.73	n/a	18
Apr ’25	US$75.28	US$84.47 +12.2%	10.7%	US$103.11	US$67.67	n/a	18
Mar ’25	n/a	US$85.77 0%	9.7%	US$104.12	US$70.50	n/a	18
Feb ’25	US$75.70	US$86.53 +14.3%	10.9%	US$104.35	US$70.65	n/a	19
Jan ’25	n/a	US$86.00 0%	13.2%	US$108.79	US$65.27	n/a	19
Dec ’24	US$76.51	US$86.63 +13.2%	13.2%	US$109.08	US$65.45	n/a	19
Nov ’24	US$66.17	US$85.48 +29.2%	12.0%	US$105.66	US$63.40	US$65.60	19
Oct ’24	n/a	US$88.05 0%	8.6%	US$99.38	US$72.42	US$68.05	19
Sep ’24	n/a	US$90.61 0%	10.1%	US$109.41	US$74.95	n/a	19
Aug ’24	n/a	US$90.73 0%	10.1%	US$109.83	US$75.23	US$60.10	19
Jul ’24	n/a	US$89.73 0%	11.0%	US$109.15	US$68.76	n/a	19
Jun ’24	n/a	US$87.07 0%	15.6%	US$108.40	US$46.09	n/a	20
May ’24	n/a	US$87.27 0%	15.5%	US$110.19	US$46.85	n/a	20
Apr ’24	US$72.55	US$83.05 +14.5%	16.5%	US$108.41	US$46.10	US$75.28	20
Mar ’24	US$74.47	US$81.29 +9.2%	16.4%	US$106.02	US$45.08	n/a	20
Feb ’24	US$76.42	US$82.12 +7.5%	16.6%	US$108.66	US$46.20	US$75.70	20
Jan ’24	n/a	US$83.66 0%	18.3%	US$116.80	US$45.15	n/a	21
Dec ’23	n/a	US$82.04 0%	18.4%	US$114.54	US$44.27	US$76.51	21
Nov ’23	US$61.88	US$78.04 +26.1%	19.0%	US$108.67	US$42.31	US$66.17	21

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.